-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
BriaCell Therapeutics Corp. quarterly/annual Operating Income (Loss) history and change rate from 2021 to Q2 2025.
- BriaCell Therapeutics Corp. Operating Income (Loss) for the quarter ending 31 Jul 2025 was -$8.55M, a 48.3% decline year-over-year.
- BriaCell Therapeutics Corp. Operating Income (Loss) for the twelve months ending 31 Jul 2025 was -$27.2M, a 18.4% increase year-over-year.
- BriaCell Therapeutics Corp. annual Operating Income (Loss) for 2025 was -$27.2M, a 18.4% increase from 2024.
- BriaCell Therapeutics Corp. annual Operating Income (Loss) for 2024 was -$33.3M, a 43.2% decline from 2023.
- BriaCell Therapeutics Corp. annual Operating Income (Loss) for 2023 was -$23.3M, a 52.2% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)